SHIELD THERAPEUTICS
Shield Therapeutics is an independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need. During 2011 Shield will be commencing global pivotal Phase III studies of its lead asset, ST10-021, for the treatment of iron deficiency anaemia associated with inflammatory bowel disease and subsequently chronic kidney disease. The Company is headquartered in Wollerau, Switzerland.
SHIELD THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Weybridge, Surrey, United Kingdom
Country:
United Kingdom
Website Url:
http://www.shieldtherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
8.2 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Font Awesome Nginx YouTube Person Schema Gravatar Profiles Typekit Amazon SSL
Current Employees Featured
Founder
Stock Details
Company's stock symbol is LSE:STX
Investors List
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series A - Shield Therapeutics
Official Site Inspections
http://www.shieldtherapeutics.com
- Host name: 167.99.200.154
- IP address: 167.99.200.154
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
Loading ... 